Jubilant Life Sciences’ arm completes acquisition of Radiopharmacy business of Triad

02 Sep 2017 Evaluate

Jubilant Life Sciences’ material wholly owned subsidiary- Jubilant Pharma (JPL) through one of its wholly owned subsidiaries has successfully completed the acquisition of the US radiopharmacy business of Triad Isotopes, Inc. on September 1, 2017.

The acquisition is a strategic fit to company’s niche nuclear medicine business and will provide Jubilant with direct access to hospital networks with ability to deliver more than 3 Million patient doses annually through approximately 1,700 customers. The company intends to maintain and expand Triad’s distribution network.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

Jubilant Pharmova Share Price

1073.90 -13.50 (-1.24%)
16-Dec-2025 11:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.20
Dr. Reddys Lab 1275.00
Cipla 1506.60
Zydus Lifesciences 922.05
Lupin 2091.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×